The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-(diethylamino)but-2-en-1-one ID: ALA4636996
PubChem CID: 78322916
Max Phase: Preclinical
Molecular Formula: C32H33ClFN5O3
Molecular Weight: 590.10
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21
Standard InChI: InChI=1S/C32H33ClFN5O3/c1-3-38(4-2)13-6-10-31(40)39-14-7-15-41-30-19-27-25(18-28(30)39)32(36-21-35-27)37-24-11-12-29(26(33)17-24)42-20-22-8-5-9-23(34)16-22/h5-6,8-12,16-19,21H,3-4,7,13-15,20H2,1-2H3,(H,35,36,37)/b10-6+
Standard InChI Key: LRVQUKBVPJMLPP-UXBLZVDNSA-N
Molfile:
RDKit 2D
42 46 0 0 0 0 0 0 0 0999 V2000
23.8430 -7.0544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8422 -5.4171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5511 -5.8249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5503 -6.6471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2615 -7.0551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9739 -6.6461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9707 -5.8207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2590 -5.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2562 -4.5909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9666 -4.1799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6791 -4.5914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3891 -4.1811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3867 -3.3589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6685 -2.9488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9615 -3.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1021 -4.5876 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.0966 -2.9428 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8104 -3.3522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5161 -2.9361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2269 -3.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9363 -2.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9329 -2.1120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2141 -1.7069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5076 -2.1206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6499 -3.3439 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.1421 -5.8277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1388 -6.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4934 -7.1613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4977 -5.3122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6914 -6.9809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6937 -5.4953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3377 -6.2387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4934 -4.4946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1989 -4.0822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7835 -4.0897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0780 -4.5021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3681 -4.0973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6626 -4.5096 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.9527 -4.1048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2472 -4.5172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6670 -5.3268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9614 -5.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27 1 1 0
1 4 2 0
3 2 2 0
2 26 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
12 16 1 0
13 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
21 25 1 0
26 27 2 0
27 28 1 0
26 29 1 0
28 30 1 0
29 31 1 0
30 32 1 0
31 32 1 0
29 33 1 0
33 34 2 0
33 35 1 0
35 36 2 0
36 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
38 41 1 0
41 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 590.10Molecular Weight (Monoisotopic): 589.2256AlogP: 6.76#Rotatable Bonds: 10Polar Surface Area: 79.82Molecular Species: BASEHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.33CX LogP: 5.89CX LogD: 3.97Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.20Np Likeness Score: -1.44
References 1. Sun M, Jia J, Sun H, Wang F.. (2020) Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold., 30 (9): [PMID:32139324 ] [10.1016/j.bmcl.2020.127045 ]